Cite
MLA Citation
A. Ranger et al.. “OP0040 Peripheral Blood Transcriptional Changes Elicited by Treatment of Systemic Lupus Erythematosus (SLE) Patients with Dapirolizumab Pegol (A Pegylated Anti-CD40L Fab').” Annals of the rheumatic diseases, vol. 75, n.d., pp. 68–69. http://access.bl.uk/ark:/81055/vdc_100135156454.0x00005c